APREPITANT

APREPITANT was reported 7527 times

APREPITANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM THORAX 39 0.6500
1 GRIP STRENGTH 121 0.5284
2 TESTICULAR GERM CELL CANCER METASTATIC 13 0.4815
3 SWOLLEN JOINT COUNT 99 0.3960
4 LUPUS VULGARIS 282 0.2238
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 127 0.1901
6 INFUSION SITE STREAKING 15 0.1724
7 PROCALCITONIN DECREASED 12 0.1714
8 C-REACTIVE PROTEIN 153 0.1650
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 314 0.1568
10 ACQUIRED PORPHYRIA 11 0.1549
11 X-RAY ABNORMAL 275 0.1536
12 PORPHYRIA ACUTE 216 0.1505
13 FACET JOINT SYNDROME 458 0.1405
14 PULMONARY SEPTAL THICKENING 12 0.1348
15 RETINITIS 229 0.1324
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 268 0.1292
17 DISLOCATION OF VERTEBRA 277 0.1213
18 DUODENAL ULCER PERFORATION 872 0.1171
19 SWOLLEN JOINT COUNT INCREASED 364 0.1140
20 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 720 0.1108
21 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 747 0.1042
22 MUSCLE INJURY 804 0.0969
23 RHEUMATIC FEVER 430 0.0964
24 COMPUTERISED TOMOGRAM THORAX ABNORMAL 66 0.0961
25 NAIL BED INFLAMMATION 30 0.0940
26 HELICOBACTER INFECTION 896 0.0871
27 FOLLICULITIS 901 0.0858
28 RHEUMATOID FACTOR POSITIVE 450 0.0778
29 TONSILLAR HAEMORRHAGE 11 0.0753
30 INTESTINAL STRANGULATION 12 0.0745
31 BONE EROSION 257 0.0726
32 C-REACTIVE PROTEIN ABNORMAL 445 0.0693
33 HAND DEFORMITY 908 0.0692
34 PERIPHERAL VENOUS DISEASE 271 0.0663
35 INTESTINAL SCARRING 12 0.0659
36 EOSINOPHIL PERCENTAGE DECREASED 13 0.0653
37 PEMPHIGUS 722 0.0577
38 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 10 0.0565
39 SEMINOMA 13 0.0546
40 COLONY STIMULATING FACTOR THERAPY 11 0.0531
41 DRUG TOLERANCE DECREASED 146 0.0519
42 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 29 0.0517
43 BREAST CANCER STAGE III 312 0.0481
44 NASAL MUCOSAL DISORDER 28 0.0480
45 LIP DRY 419 0.0461
46 SYNOVITIS 812 0.0450
47 PERICARDITIS 746 0.0444
48 APLASIA 86 0.0439
49 BLOOD CREATINE DECREASED 13 0.0430
50 GLOSSODYNIA 920 0.0411
51 MATERNAL EXPOSURE TIMING UNSPECIFIED 153 0.0407
52 IRRITABLE BOWEL SYNDROME 824 0.0384
53 JOINT RANGE OF MOTION DECREASED 477 0.0355
54 ACUTE POLYNEUROPATHY 10 0.0350
55 HYPOCHOLESTEROLAEMIA 12 0.0340
56 BURSITIS 392 0.0323
57 INTERCEPTED DRUG ADMINISTRATION ERROR 14 0.0319
58 AUTOIMMUNE DISORDER 297 0.0304
59 WOUND INFECTION 329 0.0300
60 STREPTOCOCCAL SEPSIS 35 0.0295
61 HERPES SIMPLEX REACTIVATION 11 0.0289
62 FEBRILE BONE MARROW APLASIA 118 0.0277
63 WOUND 770 0.0275
64 IMPAIRED HEALING 893 0.0272
65 DENTAL FISTULA 11 0.0264
66 EXOSTOSIS 241 0.0264
67 VASCULAR PAIN 25 0.0262
68 SERONEGATIVE ARTHRITIS 29 0.0253
69 GRIP STRENGTH DECREASED 220 0.0250
70 ALVEOLITIS 35 0.0248
71 SENSE OF OPPRESSION 29 0.0246
72 SCIATICA 386 0.0242
73 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 11 0.0240
74 LUPUS-LIKE SYNDROME 216 0.0238
75 SYSTEMIC LUPUS ERYTHEMATOSUS 844 0.0238
76 HYPERCHOLESTEROLAEMIA 227 0.0235
77 INFUSION SITE VESICLES 12 0.0228
78 NEUTROPENIC COLITIS 46 0.0222
79 AORTIC VALVE CALCIFICATION 11 0.0214
80 FIBROMYALGIA 508 0.0209
81 PSEUDOMONAL SEPSIS 36 0.0205
82 HEMIANOPIA 20 0.0202
83 WALKING AID USER 133 0.0202
84 LIVE BIRTH 168 0.0201
85 CHANGE OF BOWEL HABIT 40 0.0195
86 LOWER LIMB FRACTURE 369 0.0192
87 AORTITIS 13 0.0190
88 LOWER RESPIRATORY TRACT INFECTION 850 0.0187
89 PERIORBITAL CELLULITIS 10 0.0186
90 CONTRAINDICATED PRODUCT ADMINISTERED 562 0.0185
91 OBESITY 294 0.0184
92 HYPERMAGNESAEMIA 12 0.0184
93 C-REACTIVE PROTEIN DECREASED 12 0.0184
94 BLOOD FOLATE DECREASED 13 0.0179
95 STOMATITIS 1056 0.0174
96 ULCER HAEMORRHAGE 117 0.0173
97 ABDOMINAL SEPSIS 15 0.0170
98 STOMA SITE PAIN 25 0.0170
99 KLEBSIELLA BACTERAEMIA 16 0.0168
100 FOOT DEFORMITY 183 0.0165
101 FEBRILE NEUTROPENIA 1083 0.0163
102 HICCUPS 133 0.0162
103 INFUSION RELATED REACTION 1071 0.0161
104 PULMONARY FIBROSIS 304 0.0158
105 LARYNGEAL DISCOMFORT 10 0.0157
106 STREPTOCOCCAL BACTERAEMIA 17 0.0156
107 ATELECTASIS 150 0.0155
108 PRESCRIBED OVERDOSE 300 0.0155
109 SPUTUM ABNORMAL 10 0.0151
110 NAIL INFECTION 21 0.0146
111 CYSTITIS HAEMORRHAGIC 59 0.0146
112 TONIC CLONIC MOVEMENTS 19 0.0146
113 TUMOUR PAIN 19 0.0144
114 RED BLOOD CELL SEDIMENTATION RATE INCREASED 159 0.0144
115 BLISTER 800 0.0142
116 TYPE 2 DIABETES MELLITUS 468 0.0139
117 VASCULAR DEVICE INFECTION 63 0.0139
118 DRUG CLEARANCE DECREASED 18 0.0138
119 HYPOCHLORAEMIA 16 0.0137
120 ARTHROPATHY 751 0.0135
121 CATHETER SITE RELATED REACTION 10 0.0133
122 HEPATIC ENZYME INCREASED 895 0.0131
123 LIVER INJURY 322 0.0131
124 PALMAR ERYTHEMA 15 0.0130
125 ILL-DEFINED DISORDER 783 0.0129
126 SUPERINFECTION BACTERIAL 10 0.0126
127 FACIAL ASYMMETRY 12 0.0126
128 DISCOMFORT 763 0.0125
129 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 22 0.0124
130 HEPATIC CIRRHOSIS 225 0.0120
131 NIGHT SWEATS 382 0.0118
132 FIXED ERUPTION 20 0.0116
133 IMMUNE-MEDIATED HYPOTHYROIDISM 13 0.0115
134 HYPERAMMONAEMIC ENCEPHALOPATHY 20 0.0115
135 HAIR DISORDER 94 0.0114
136 LIVER DISORDER 504 0.0114
137 MUCOSAL INFLAMMATION 297 0.0113
138 THERAPEUTIC PRODUCT EFFECT DECREASED 508 0.0113
139 PRESCRIBED UNDERDOSE 226 0.0113
140 BLOOD UREA DECREASED 14 0.0113
141 PREGNANCY 225 0.0112
142 THROMBOCYTOPENIC PURPURA 15 0.0110
143 JOINT DISLOCATION 114 0.0108
144 HEPATOCELLULAR INJURY 151 0.0106
145 SUBILEUS 22 0.0106
146 EYE INJURY 32 0.0105
147 PSORIATIC ARTHROPATHY 427 0.0105
148 SLEEP DISORDER 742 0.0105
149 PSYCHOLOGICAL TRAUMA 90 0.0104
150 INTESTINAL ISCHAEMIA 57 0.0103
151 PARONYCHIA 45 0.0102
152 GASTROINTESTINAL DISORDER 913 0.0102
153 EOSINOPHIL COUNT DECREASED 24 0.0101
154 CANDIDA SEPSIS 9 0.0100
155 CEREBELLAR SYNDROME 22 0.0100
156 ONYCHALGIA 10 0.0100
157 ROAD TRAFFIC ACCIDENT 414 0.0099
158 TOXIC ENCEPHALOPATHY 50 0.0099
159 ALOPECIA AREATA 17 0.0097
160 INJURY 681 0.0097
161 CAPILLARY LEAK SYNDROME 20 0.0097
162 VENA CAVA THROMBOSIS 16 0.0096
163 CARBON DIOXIDE DECREASED 11 0.0095
164 WEIGHT FLUCTUATION 100 0.0095
165 AORTIC THROMBOSIS 11 0.0095
166 RADIATION SKIN INJURY 11 0.0095
167 FREQUENT BOWEL MOVEMENTS 256 0.0095
168 LEFT ATRIAL DILATATION 12 0.0094
169 DEATH NEONATAL 13 0.0093
170 BLOOD CHLORIDE DECREASED 24 0.0093
171 SECONDARY ADRENOCORTICAL INSUFFICIENCY 14 0.0093
172 ABDOMINAL OPERATION 12 0.0092
173 BODY TEMPERATURE ABNORMAL 17 0.0092
174 DELIRIUM 319 0.0092
175 ENTERITIS 58 0.0091
176 HAIR COLOUR CHANGES 112 0.0090
177 IMMUNE-MEDIATED ENTEROCOLITIS 33 0.0090
178 ENCEPHALOPATHY 220 0.0089
179 SWELLING 837 0.0089
180 WHEEZING 528 0.0089
181 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 91 0.0089
182 HIP ARTHROPLASTY 135 0.0088
183 LUNG DISORDER 427 0.0087
184 NEUTROPHIL COUNT DECREASED 352 0.0086
185 MADAROSIS 100 0.0086
186 OESOPHAGITIS 94 0.0086
187 PHARYNGEAL ERYTHEMA 18 0.0085
188 BLOOD CHOLESTEROL INCREASED 393 0.0084
189 CONTUSION 810 0.0084
190 SINUSITIS 856 0.0083
191 HAIR TEXTURE ABNORMAL 111 0.0083
192 BICYTOPENIA 16 0.0082
193 HEPATIC CYTOLYSIS 104 0.0081
194 INFLAMMATION 420 0.0081
195 CYTOLYTIC HEPATITIS 27 0.0081
196 GENERAL PHYSICAL HEALTH DETERIORATION 940 0.0081
197 EAR INFECTION 215 0.0081
198 BONE MARROW FAILURE 164 0.0081
199 PERIPHERAL SENSORY NEUROPATHY 47 0.0080
200 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 10 0.0080
201 GAIT INABILITY 266 0.0080
202 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 134 0.0079
203 PUSTULAR PSORIASIS 27 0.0079
204 MEDICATION ERROR 433 0.0078
205 INFUSION SITE IRRITATION 10 0.0078
206 C-REACTIVE PROTEIN INCREASED 281 0.0077
207 POST HERPETIC NEURALGIA 11 0.0076
208 ATRIOVENTRICULAR BLOCK SECOND DEGREE 23 0.0076
209 ANORECTAL DISORDER 15 0.0075
210 MUSCULOSKELETAL PAIN 394 0.0075
211 EAR PAIN 146 0.0075
212 LARGE INTESTINE PERFORATION 52 0.0075
213 OSTEOARTHRITIS 317 0.0075
214 APLASTIC ANAEMIA 39 0.0075
215 SPONDYLITIS 27 0.0074
216 TONGUE ULCERATION 25 0.0074
217 OEDEMA 400 0.0074
218 THERAPY NON-RESPONDER 331 0.0074
219 ELECTROCARDIOGRAM T WAVE INVERSION 16 0.0072
220 DIABETIC METABOLIC DECOMPENSATION 10 0.0072
221 HYPERTHERMIA 55 0.0072
222 RASH MACULO-PAPULAR 159 0.0071
223 NEUTROPENIC SEPSIS 51 0.0071
224 STAPHYLOCOCCUS TEST POSITIVE 15 0.0071
225 ENTEROCOLITIS 41 0.0071
226 TONIC CONVULSION 10 0.0071
227 ANAPHYLACTOID REACTION 29 0.0070
228 INFUSION SITE REACTION 21 0.0070
229 RHEUMATOID ARTHRITIS 793 0.0070
230 TONGUE COATED 12 0.0069
231 HYPOMAGNESAEMIA 96 0.0069
232 JOINT SWELLING 830 0.0069
233 ALOPECIA 1349 0.0069
234 BLEPHAROSPASM 43 0.0068
235 HYPOPHOSPHATAEMIA 50 0.0068
236 JUGULAR VEIN THROMBOSIS 12 0.0067
237 PHLEBITIS 34 0.0066
238 INFECTION 961 0.0066
239 SOFT TISSUE INFECTION 12 0.0066
240 HYPOKALAEMIA 302 0.0065
241 GASTROINTESTINAL NECROSIS 19 0.0065
242 HYPERSENSITIVITY 1207 0.0065
243 OTOTOXICITY 12 0.0065
244 REGURGITATION 22 0.0064
245 BREAST CANCER STAGE II 53 0.0064
246 MOBILITY DECREASED 457 0.0064
247 NON-CARDIAC CHEST PAIN 20 0.0063
248 SPLENIC INFARCTION 11 0.0063
249 KERATITIS 19 0.0062
250 DRUG INTOLERANCE 601 0.0062
251 RECTAL HAEMORRHAGE 267 0.0062
252 ORAL PAIN 139 0.0062
253 DERMATITIS ACNEIFORM 37 0.0061
254 CONFUSIONAL STATE 981 0.0061
255 NAIL DISORDER 53 0.0061
256 TUMOUR LYSIS SYNDROME 53 0.0060
257 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
258 VARICOSE VEIN 31 0.0060
259 RASH VESICULAR 29 0.0060
260 FLUID INTAKE REDUCED 30 0.0060
261 FEELING HOT 364 0.0059
262 METASTASES TO LYMPH NODES 40 0.0059
263 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
264 EROSIVE OESOPHAGITIS 10 0.0059
265 ABDOMINAL RIGIDITY 16 0.0059
266 LEFT VENTRICULAR DYSFUNCTION 39 0.0058
267 MATERNAL EXPOSURE DURING PREGNANCY 517 0.0058
268 HYPOXIA 203 0.0058
269 THROMBOCYTOPENIA 643 0.0057
270 ARTERIOSPASM CORONARY 23 0.0057
271 THROMBOPHLEBITIS 20 0.0057
272 KNEE ARTHROPLASTY 120 0.0057
273 WHITE BLOOD CELL COUNT INCREASED 218 0.0057
274 HYPONATRAEMIA 320 0.0057
275 DRY MOUTH 460 0.0057
276 JOINT STIFFNESS 148 0.0056
277 IMMUNE-MEDIATED HEPATIC DISORDER 11 0.0056
278 CHEMOTHERAPY 21 0.0055
279 GASTROINTESTINAL PERFORATION 23 0.0055
280 CLONUS 15 0.0055
281 TOXIC SKIN ERUPTION 55 0.0055
282 ANAPHYLACTIC SHOCK 140 0.0054
283 INTERSTITIAL LUNG DISEASE 262 0.0054
284 HYPERAMMONAEMIA 27 0.0054
285 COLITIS ULCERATIVE 239 0.0053
286 BLOOD CULTURE POSITIVE 16 0.0053
287 TOXIC EPIDERMAL NECROLYSIS 81 0.0053
288 VENOUS THROMBOSIS LIMB 11 0.0053
289 OSTEOPOROSIS 219 0.0053
290 CHOLANGITIS 33 0.0053
291 PROTEIN TOTAL DECREASED 20 0.0053
292 TREATMENT FAILURE 440 0.0053
293 FEMALE GENITAL TRACT FISTULA 9 0.0053
294 CARDIOTOXICITY 47 0.0053
295 LUNG CANCER METASTATIC 15 0.0052
296 VITAMIN B12 DEFICIENCY 21 0.0052
297 MOUTH ULCERATION 109 0.0052
298 GASTRIC PERFORATION 14 0.0051
299 NEUTROPENIA 697 0.0051
300 LABORATORY TEST ABNORMAL 150 0.0051
301 DISSEMINATED INTRAVASCULAR COAGULATION 71 0.0050
302 HYPERNATRAEMIA 25 0.0050
303 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 86 0.0050
304 DRUG-INDUCED LIVER INJURY 157 0.0050
305 PANCYTOPENIA 279 0.0050
306 ILEUS 62 0.0050
307 ABDOMINAL DISCOMFORT 835 0.0050
308 RENAL TUBULAR DISORDER 14 0.0050
309 NEUROPATHY PERIPHERAL 473 0.0050
310 CEREBRAL VENOUS THROMBOSIS 9 0.0050
311 LEUKOPENIA 248 0.0050
312 GENERALISED ERYTHEMA 28 0.0049
313 DECREASED APPETITE 1142 0.0049
314 PERIPHERAL SWELLING 757 0.0049
315 PANCREATITIS 259 0.0049
316 IMMUNE-MEDIATED HEPATITIS 10 0.0049
317 PYREXIA 1686 0.0049
318 SUSPECTED OFF LABEL USE 22 0.0049
319 ODYNOPHAGIA 29 0.0049
320 INTENTIONAL PRODUCT USE ISSUE 425 0.0048
321 MUSCULOSKELETAL STIFFNESS 425 0.0048
322 IMMUNE THROMBOCYTOPENIA 22 0.0048
323 VENOOCCLUSIVE DISEASE 12 0.0048
324 CHOLESTASIS 92 0.0048
325 RESPIRATORY DISORDER 143 0.0048
326 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
327 NASOPHARYNGITIS 865 0.0047
328 RADIATION PNEUMONITIS 10 0.0047
329 MIXED LIVER INJURY 14 0.0046
330 BLOOD PHOSPHORUS DECREASED 17 0.0046
331 PULSE ABSENT 22 0.0046
332 EXTRAVASATION 19 0.0046
333 SEPTIC SHOCK 201 0.0046
334 METASTASES TO CENTRAL NERVOUS SYSTEM 59 0.0046
335 OROPHARYNGEAL DISCOMFORT 41 0.0045
336 ONYCHOMADESIS 19 0.0045
337 PANCREATITIS ACUTE 101 0.0045
338 ADENOCARCINOMA 10 0.0045
339 LARYNGOSPASM 12 0.0045
340 AMNESIA 289 0.0044
341 INFUSION SITE PRURITUS 14 0.0044
342 PULMONARY TOXICITY 31 0.0044
343 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 102 0.0044
344 URINARY TRACT INFECTION BACTERIAL 11 0.0043
345 DRUG TOLERANCE 22 0.0043
346 MYOSITIS 39 0.0043
347 RASH MORBILLIFORM 12 0.0043
348 HEPATITIS CHOLESTATIC 26 0.0043
349 INTRACRANIAL PRESSURE INCREASED 24 0.0043
350 BODY TEMPERATURE INCREASED 87 0.0043
351 NEUTROPHIL COUNT ABNORMAL 12 0.0042
352 HYPOALBUMINAEMIA 33 0.0042
353 MENINGITIS ASEPTIC 19 0.0042
354 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
355 POOR PERIPHERAL CIRCULATION 18 0.0042
356 OEDEMA PERIPHERAL 512 0.0042
357 ANAPHYLACTIC REACTION 232 0.0042
358 TONGUE OEDEMA 16 0.0042
359 PERIPHERAL ISCHAEMIA 17 0.0042
360 BLOOD ALBUMIN DECREASED 33 0.0042
361 MUSCLE SPASTICITY 51 0.0041
362 SUPRAVENTRICULAR EXTRASYSTOLES 14 0.0041
363 APHTHOUS ULCER 32 0.0041
364 GAMMA-GLUTAMYLTRANSFERASE INCREASED 91 0.0041
365 EMBOLISM 34 0.0041
366 PNEUMOCYSTIS JIROVECII PNEUMONIA 41 0.0041
367 STRIDOR 12 0.0041
368 BLOOD MAGNESIUM DECREASED 35 0.0041
369 VENOOCCLUSIVE LIVER DISEASE 20 0.0040
370 INFUSION SITE ERYTHEMA 34 0.0040
371 AORTIC STENOSIS 14 0.0040
372 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
373 TYPE I HYPERSENSITIVITY 14 0.0040
374 EPILEPSY 121 0.0040
375 DEAFNESS NEUROSENSORY 13 0.0039
376 COLITIS 149 0.0039
377 ELECTROLYTE IMBALANCE 45 0.0039
378 DERMATITIS BULLOUS 28 0.0039
379 PANCREATIC CARCINOMA METASTATIC 11 0.0039
380 CATHETER SITE PAIN 10 0.0039
381 LUNG INFILTRATION 34 0.0038
382 DISABILITY 76 0.0038
383 POLYNEUROPATHY 46 0.0038
384 AGRANULOCYTOSIS 71 0.0038
385 ILEUS PARALYTIC 17 0.0038
386 LIPASE INCREASED 29 0.0038
387 WEIGHT INCREASED 839 0.0037
388 ACUTE PULMONARY OEDEMA 21 0.0037
389 INFUSION SITE PAIN 48 0.0037
390 LUMBAR VERTEBRAL FRACTURE 17 0.0037
391 HYPOAESTHESIA 554 0.0037
392 STAPHYLOCOCCAL BACTERAEMIA 16 0.0037
393 JAUNDICE CHOLESTATIC 13 0.0037
394 HYPERBILIRUBINAEMIA 38 0.0037
395 ADVERSE EVENT 337 0.0037
396 ABDOMINAL TENDERNESS 18 0.0036
397 EXPOSURE DURING PREGNANCY 223 0.0036
398 BRAIN OEDEMA 45 0.0036
399 GASTROINTESTINAL MOTILITY DISORDER 19 0.0035
400 CYTOKINE RELEASE SYNDROME 71 0.0035
401 CEREBRAL THROMBOSIS 10 0.0035
402 CANCER PAIN 9 0.0035
403 SPUTUM DISCOLOURED 33 0.0035
404 HYPERTENSION 736 0.0035
405 SPINAL FUSION SURGERY 14 0.0034
406 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
407 HYPERTRANSAMINASAEMIA 24 0.0034
408 URTICARIA 577 0.0034
409 BRONCHOSPASM 49 0.0034
410 HYPOVOLAEMIA 20 0.0034
411 DYSPEPSIA 335 0.0034
412 WHITE BLOOD CELL COUNT DECREASED 368 0.0034
413 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
414 THORACIC VERTEBRAL FRACTURE 10 0.0034
415 HYPOVENTILATION 11 0.0034
416 INFUSION SITE EXTRAVASATION 21 0.0034
417 VOMITING 1578 0.0034
418 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 26 0.0033
419 PARAESTHESIA 526 0.0033
420 ORAL CANDIDIASIS 44 0.0033
421 GASTROINTESTINAL TOXICITY 16 0.0033
422 HYPOCALCAEMIA 63 0.0033
423 CHEST PAIN 616 0.0033
424 ERYTHEMA MULTIFORME 31 0.0033
425 DEVICE RELATED INFECTION 51 0.0033
426 FLANK PAIN 31 0.0033
427 EMBOLISM VENOUS 10 0.0033
428 DYSAESTHESIA 10 0.0033
429 DUODENITIS 10 0.0033
430 CANDIDA INFECTION 55 0.0033
431 TACHYCARDIA 289 0.0032
432 INSOMNIA 861 0.0032
433 ORGANISING PNEUMONIA 16 0.0032
434 ADRENAL INSUFFICIENCY 39 0.0032
435 ENDOTRACHEAL INTUBATION 9 0.0032
436 TASTE DISORDER 65 0.0032
437 APLASIA PURE RED CELL 11 0.0032
438 ASPIRATION 35 0.0032
439 HYPERURICAEMIA 13 0.0032
440 FAECES SOFT 23 0.0032
441 PLATELET COUNT INCREASED 41 0.0031
442 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
443 ESCHERICHIA SEPSIS 9 0.0031
444 FIBRIN D DIMER INCREASED 11 0.0031
445 HALLUCINATIONS, MIXED 13 0.0031
446 PLATELET COUNT DECREASED 328 0.0031
447 SKIN FISSURES 60 0.0031
448 GENERAL SYMPTOM 23 0.0031
449 VULVOVAGINAL MYCOTIC INFECTION 12 0.0030
450 POLYDIPSIA 12 0.0030
451 IRON DEFICIENCY ANAEMIA 28 0.0030
452 BACTERAEMIA 36 0.0030
453 ATYPICAL PNEUMONIA 9 0.0030
454 RENAL FAILURE ACUTE 127 0.0030
455 ASTHMA 338 0.0030
456 COLITIS ISCHAEMIC 20 0.0030
457 RASH 1291 0.0030
458 TRANSFUSION 31 0.0030
459 FEEDING DISORDER 60 0.0030
460 HEPATIC FUNCTION ABNORMAL 110 0.0029
461 ABDOMINAL PAIN 678 0.0029
462 HAEMOLYTIC ANAEMIA 26 0.0029
463 EJECTION FRACTION DECREASED 45 0.0029
464 NAUSEA 2289 0.0029
465 DYSPNOEA 1633 0.0029
466 PRURITUS 1103 0.0029
467 BLOOD UREA INCREASED 48 0.0029
468 PNEUMONITIS 78 0.0029
469 EOSINOPHILIC PNEUMONIA 9 0.0029
470 MUSCLE CONTRACTIONS INVOLUNTARY 10 0.0028
471 SKIN TOXICITY 16 0.0028
472 LYMPHOPENIA 40 0.0028
473 MUSCULAR WEAKNESS 321 0.0028
474 HYPOPHAGIA 72 0.0028
475 FLUSHING 286 0.0028
476 VEIN DISORDER 14 0.0028
477 HEPATITIS 71 0.0028
478 BACTERIAL SEPSIS 9 0.0028
479 DRUG INTERACTION 438 0.0028
480 LARYNGEAL OEDEMA 17 0.0028
481 HYPERTRIGLYCERIDAEMIA 16 0.0027
482 THROMBOCYTOSIS 10 0.0027
483 MOUTH HAEMORRHAGE 20 0.0027
484 OXYGEN SATURATION DECREASED 153 0.0027
485 HAEMOLYSIS 21 0.0027
486 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
487 NON-SMALL CELL LUNG CANCER 13 0.0027
488 IMPAIRED QUALITY OF LIFE 39 0.0027
489 TRISMUS 14 0.0027
490 ABDOMINAL PAIN UPPER 558 0.0027
491 SKIN REACTION 38 0.0027
492 ACUTE KIDNEY INJURY 411 0.0027
493 RETINOPATHY 10 0.0027
494 JAUNDICE 72 0.0027
495 RENAL TUBULAR NECROSIS 26 0.0026
496 CONSTIPATION 578 0.0026
497 DEHYDRATION 350 0.0026
498 SMALL FOR DATES BABY 13 0.0026
499 DEEP VEIN THROMBOSIS 170 0.0026
500 ANAEMIA 498 0.0026
501 PNEUMOTHORAX 41 0.0026
502 FATIGUE 2013 0.0026
503 INTESTINAL PERFORATION 29 0.0026
504 ROSACEA 12 0.0026
505 HYPOTHERMIA 26 0.0026
506 DIARRHOEA 1651 0.0026
507 ANURIA 22 0.0026
508 PLEURAL EFFUSION 155 0.0025
509 INFUSION SITE SWELLING 16 0.0025
510 GENERALISED TONIC-CLONIC SEIZURE 42 0.0025
511 SINUS HEADACHE 15 0.0025
512 OESOPHAGEAL CANDIDIASIS 10 0.0025
513 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 120 0.0025
514 PULMONARY ALVEOLAR HAEMORRHAGE 14 0.0025
515 ERYTHEMA 513 0.0025
516 PROCTALGIA 16 0.0025
517 DRUG ERUPTION 44 0.0025
518 PRODUCT USE ISSUE 465 0.0025
519 CONDITION AGGRAVATED 752 0.0025
520 LIVER FUNCTION TEST INCREASED 53 0.0025
521 ASTHENIA 928 0.0025
522 EPISTAXIS 184 0.0025
523 SUDDEN DEATH 26 0.0025
524 RECURRENT CANCER 10 0.0024
525 UPPER RESPIRATORY TRACT INFECTION 113 0.0024
526 LYMPHOCYTE COUNT DECREASED 43 0.0024
527 MEMORY IMPAIRMENT 334 0.0024
528 MUSCLE SPASMS 443 0.0024
529 BLOOD BILIRUBIN INCREASED 65 0.0024
530 RASH PRURITIC 130 0.0024
531 DERMATITIS EXFOLIATIVE 12 0.0024
532 NORMAL NEWBORN 13 0.0024
533 KLEBSIELLA INFECTION 12 0.0024
534 CIRCULATORY COLLAPSE 40 0.0023
535 ARTHRITIS 184 0.0023
536 TRANSAMINASES INCREASED 52 0.0023
537 MIGRAINE 223 0.0023
538 CACHEXIA 12 0.0023
539 TEARFULNESS 10 0.0023
540 PERITONITIS 48 0.0023
541 ASPARTATE AMINOTRANSFERASE INCREASED 123 0.0023
542 ASCITES 68 0.0023
543 SPINAL PAIN 27 0.0023
544 CHOLECYSTITIS ACUTE 13 0.0023
545 POLYARTHRITIS 12 0.0023
546 PIGMENTATION DISORDER 14 0.0023
547 HAEMORRHOIDAL HAEMORRHAGE 11 0.0023
548 CARDIO-RESPIRATORY ARREST 94 0.0022
549 UNDERDOSE 164 0.0022
550 BLEPHARITIS 9 0.0022
551 HAEMODYNAMIC INSTABILITY 17 0.0022
552 BREATH SOUNDS ABNORMAL 11 0.0022
553 ARTHRALGIA 923 0.0022
554 PAPILLOEDEMA 10 0.0022
555 SEPSIS 247 0.0022
556 PULMONARY EMBOLISM 209 0.0022
557 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 13 0.0022
558 ORAL DISORDER 16 0.0022
559 NEUROTOXICITY 38 0.0022
560 STREPTOCOCCAL INFECTION 12 0.0022
561 MALNUTRITION 24 0.0021
562 WEIGHT DECREASED 598 0.0021
563 CYTOPENIA 26 0.0021
564 FAILURE TO THRIVE 11 0.0021
565 ALANINE AMINOTRANSFERASE INCREASED 129 0.0021
566 MALAISE 921 0.0021
567 MYOCARDITIS 24 0.0021
568 SUBCUTANEOUS ABSCESS 10 0.0021
569 PNEUMONIA 673 0.0021
570 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
571 ESCHERICHIA INFECTION 17 0.0021
572 PRODUCT LABEL CONFUSION 12 0.0021
573 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
574 PURPURA 18 0.0020
575 METABOLIC ACIDOSIS 65 0.0020
576 SMALL INTESTINAL OBSTRUCTION 25 0.0020
577 LYMPHOEDEMA 14 0.0020
578 PARAESTHESIA ORAL 29 0.0020
579 CEREBRAL INFARCTION 49 0.0020
580 HYDRONEPHROSIS 15 0.0020
581 CHEST DISCOMFORT 205 0.0020
582 RESPIRATORY DISTRESS 55 0.0020
583 METASTASES TO LIVER 35 0.0020
584 ERYSIPELAS 10 0.0020
585 ALTERED STATE OF CONSCIOUSNESS 43 0.0020
586 DYSGEUSIA 147 0.0020
587 VISUAL IMPAIRMENT 245 0.0020
588 VAGINAL DISCHARGE 20 0.0020
589 BLOOD SODIUM DECREASED 37 0.0020
590 MALIGNANT NEOPLASM PROGRESSION 201 0.0020
591 ISCHAEMIC STROKE 35 0.0020
592 PRODUCT USE IN UNAPPROVED INDICATION 486 0.0020
593 PETIT MAL EPILEPSY 10 0.0020
594 HYPOTENSION 392 0.0020
595 CARDIAC FAILURE ACUTE 13 0.0019
596 EAR DISCOMFORT 20 0.0019
597 CHILLS 228 0.0019
598 URINE OUTPUT DECREASED 17 0.0019
599 RESTLESSNESS 71 0.0019
600 OLIGURIA 12 0.0019
601 PETECHIAE 20 0.0019
602 HAEMATOCRIT DECREASED 38 0.0019
603 TONSILLITIS 10 0.0019
604 ATRIAL FIBRILLATION 186 0.0019
605 ADVERSE DRUG REACTION 171 0.0019
606 SINUS TACHYCARDIA 27 0.0019
607 FACE OEDEMA 32 0.0019
608 DISEASE PROGRESSION 224 0.0019
609 RED BLOOD CELL COUNT DECREASED 54 0.0019
610 MYELOSUPPRESSION 68 0.0019
611 FEELING OF BODY TEMPERATURE CHANGE 11 0.0019
612 ACUTE RESPIRATORY FAILURE 36 0.0019
613 APHAGIA 9 0.0019
614 HYPERTHYROIDISM 27 0.0019
615 HAEMATEMESIS 47 0.0019
616 PROTEINURIA 35 0.0018
617 HYDROCEPHALUS 10 0.0018
618 INTESTINAL OBSTRUCTION 69 0.0018
619 HYPERGLYCAEMIA 66 0.0018
620 NEURALGIA 44 0.0018
621 CONGENITAL ANOMALY 14 0.0018
622 EYELID OEDEMA 21 0.0018
623 MULTI-ORGAN FAILURE 31 0.0018
624 LACRIMATION INCREASED 54 0.0018
625 UNRESPONSIVE TO STIMULI 46 0.0018
626 CONJUNCTIVITIS 33 0.0018
627 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
628 TACHYPNOEA 24 0.0018
629 GINGIVAL PAIN 14 0.0018
630 MYOCARDIAL ISCHAEMIA 20 0.0018
631 BACK PAIN 408 0.0018
632 BLOOD CREATININE INCREASED 114 0.0017
633 SUNBURN 13 0.0017
634 MENTAL STATUS CHANGES 48 0.0017
635 HAEMATURIA 59 0.0017
636 APHASIA 52 0.0017
637 PAIN 1056 0.0017
638 CYANOSIS 27 0.0017
639 GASTROENTERITIS 25 0.0017
640 METASTASES TO BONE 28 0.0017
641 INCONTINENCE 18 0.0017
642 DUODENAL ULCER 12 0.0017
643 GENERALISED OEDEMA 21 0.0017
644 PHARYNGITIS 21 0.0017
645 PAIN IN EXTREMITY 494 0.0017
646 OFF LABEL USE 1453 0.0017
647 SINUS BRADYCARDIA 16 0.0017
648 BACK INJURY 18 0.0017
649 HAEMOGLOBIN DECREASED 169 0.0016
650 ANXIETY 468 0.0016
651 THROMBOTIC MICROANGIOPATHY 16 0.0016
652 PNEUMONIA BACTERIAL 15 0.0016
653 RESPIRATORY DEPRESSION 20 0.0016
654 TENDERNESS 17 0.0016
655 THROAT TIGHTNESS 44 0.0016
656 DYSPHAGIA 154 0.0016
657 RHINITIS 13 0.0016
658 KETOACIDOSIS 12 0.0016
659 ERUCTATION 31 0.0016
660 FISTULA 18 0.0016
661 BLOOD CALCIUM DECREASED 18 0.0016
662 EATING DISORDER 34 0.0016
663 CHOLECYSTITIS 19 0.0016
664 GAIT DISTURBANCE 303 0.0016
665 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
666 ACIDOSIS 12 0.0016
667 DYSARTHRIA 59 0.0016
668 MUSCLE TWITCHING 36 0.0016
669 AFFECT LABILITY 15 0.0016
670 HEPATIC STEATOSIS 29 0.0016
671 HEPATITIS ACUTE 10 0.0015
672 HAEMORRHOIDS 30 0.0015
673 BACK DISORDER 25 0.0015
674 THERAPEUTIC RESPONSE DECREASED 93 0.0015
675 COMA 73 0.0015
676 BLOOD URINE PRESENT 29 0.0015
677 DEPRESSION 345 0.0015
678 NEPHROPATHY TOXIC 17 0.0015
679 PYELONEPHRITIS 13 0.0015
680 SEIZURE 173 0.0015
681 MENINGITIS 10 0.0015
682 OROPHARYNGEAL PAIN 138 0.0015
683 BREAST CANCER METASTATIC 16 0.0015
684 MUSCULOSKELETAL CHEST PAIN 23 0.0015
685 LUNG INFECTION 23 0.0015
686 METASTASES TO LUNG 17 0.0015
687 BONE PAIN 86 0.0015
688 PRODUCTIVE COUGH 70 0.0015
689 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
690 CARDIOGENIC SHOCK 21 0.0015
691 HYPERCALCAEMIA 18 0.0015
692 JOINT EFFUSION 10 0.0014
693 GASTROINTESTINAL INFECTION 13 0.0014
694 BRONCHITIS 107 0.0014
695 GASTRITIS 38 0.0014
696 AUTOIMMUNE HEPATITIS 10 0.0014
697 NEOPLASM PROGRESSION 50 0.0014
698 BOWEL MOVEMENT IRREGULARITY 11 0.0014
699 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 102 0.0014
700 ADVERSE REACTION 19 0.0014
701 RESPIRATORY FAILURE 104 0.0014
702 RESPIRATORY TRACT INFECTION 37 0.0014
703 STATUS EPILEPTICUS 16 0.0014
704 MELAENA 31 0.0014
705 NECK PAIN 78 0.0014
706 COUGH 391 0.0014
707 DIZZINESS 695 0.0014
708 GINGIVAL BLEEDING 19 0.0014
709 MOTOR DYSFUNCTION 14 0.0014
710 RASH PUSTULAR 10 0.0014
711 RASH ERYTHEMATOUS 65 0.0014
712 HEADACHE 849 0.0014
713 HYPERTENSIVE CRISIS 15 0.0013
714 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
715 ANAL INCONTINENCE 12 0.0013
716 SYNCOPE 133 0.0013
717 HEPATIC FAILURE 40 0.0013
718 PNEUMONIA ASPIRATION 33 0.0013
719 HYPERHIDROSIS 169 0.0013
720 HEPATOTOXICITY 29 0.0013
721 HEMIPARESIS 22 0.0013
722 BRONCHOPULMONARY ASPERGILLOSIS 10 0.0013
723 APNOEA 10 0.0013
724 HYPERKALAEMIA 45 0.0013
725 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
726 DRUG LEVEL DECREASED 13 0.0013
727 TORSADE DE POINTES 10 0.0013
728 EMOTIONAL DISORDER 39 0.0013
729 RENAL IMPAIRMENT 106 0.0013
730 SHOCK 29 0.0013
731 STEVENS-JOHNSON SYNDROME 28 0.0013
732 MYOCLONUS 15 0.0013
733 SKIN INFECTION 14 0.0012
734 MYDRIASIS 16 0.0012
735 PERIPHERAL COLDNESS 17 0.0012
736 HALLUCINATION, VISUAL 26 0.0012
737 DISORIENTATION 48 0.0012
738 PHOTOSENSITIVITY REACTION 20 0.0012
739 CARDIAC FAILURE 97 0.0012
740 GASTROOESOPHAGEAL REFLUX DISEASE 97 0.0012
741 PHARYNGITIS STREPTOCOCCAL 13 0.0012
742 COLD SWEAT 21 0.0012
743 DEPRESSED LEVEL OF CONSCIOUSNESS 47 0.0012
744 GASTROINTESTINAL PAIN 13 0.0012
745 ORAL HERPES 23 0.0012
746 PALLOR 32 0.0012
747 RASH MACULAR 41 0.0012
748 RETCHING 25 0.0012
749 NEUTROPHIL COUNT INCREASED 12 0.0012
750 PHARYNGEAL OEDEMA 18 0.0012
751 PHOTOPHOBIA 22 0.0012
752 CONVULSION 66 0.0012
753 STAPHYLOCOCCAL INFECTION 38 0.0012
754 ATRIAL FLUTTER 9 0.0011
755 PERICARDIAL EFFUSION 26 0.0011
756 INTERNATIONAL NORMALISED RATIO INCREASED 32 0.0011
757 FACIAL PAIN 10 0.0011
758 HOSPICE CARE 11 0.0011
759 BRADYCARDIA 59 0.0011
760 LEUKOCYTOSIS 20 0.0011
761 RENAL FAILURE 146 0.0011
762 PAIN IN JAW 31 0.0011
763 ECZEMA 57 0.0011
764 SWOLLEN TONGUE 34 0.0011
765 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
766 BLOOD PRESSURE DECREASED 72 0.0011
767 EOSINOPHIL COUNT INCREASED 9 0.0011
768 RHINORRHOEA 69 0.0011
769 CARDIAC ARREST 88 0.0011
770 BLOOD POTASSIUM DECREASED 32 0.0011
771 THIRST 19 0.0011
772 HOT FLUSH 80 0.0011
773 RASH GENERALISED 27 0.0010
774 VASCULITIS 12 0.0010
775 EOSINOPHILIA 18 0.0010
776 DRUG LEVEL INCREASED 17 0.0010
777 PLASMA CELL MYELOMA 40 0.0010
778 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
779 PULMONARY THROMBOSIS 11 0.0010
780 DYSPNOEA EXERTIONAL 38 0.0010
781 ANOREXIA 13 0.0010
782 LETHARGY 58 0.0010
783 PULMONARY MASS 15 0.0010
784 COLON CANCER 15 0.0010
785 AGEUSIA 25 0.0010
786 HYPOTHYROIDISM 32 0.0010
787 GASTRIC ULCER 19 0.0010
788 DEVICE OCCLUSION 14 0.0010
789 ANGINA PECTORIS 28 0.0010
790 LOSS OF CONSCIOUSNESS 125 0.0010
791 CARDIOMEGALY 12 0.0010
792 LOCAL SWELLING 17 0.0010
793 APPENDICITIS 9 0.0010
794 VENTRICULAR EXTRASYSTOLES 10 0.0010
795 ACUTE MYELOID LEUKAEMIA 15 0.0010
796 URINARY RETENTION 32 0.0010
797 DERMATITIS 20 0.0010
798 DYSURIA 35 0.0009
799 TREATMENT NONCOMPLIANCE 52 0.0009
800 NO ADVERSE EVENT 172 0.0009
801 CARDIOMYOPATHY 14 0.0009
802 THROMBOSIS 76 0.0009
803 PRODUCT PHYSICAL ISSUE 19 0.0009
804 IMMUNODEFICIENCY 14 0.0009
805 MUSCULOSKELETAL DISCOMFORT 16 0.0009
806 LIVER FUNCTION TEST ABNORMAL 27 0.0009
807 EXTRAPYRAMIDAL DISORDER 23 0.0009
808 SWELLING FACE 60 0.0009
809 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
810 VERTIGO 55 0.0009
811 DIVERTICULITIS 25 0.0009
812 ABDOMINAL DISTENSION 93 0.0009
813 INCREASED APPETITE 17 0.0009
814 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
815 MITRAL VALVE INCOMPETENCE 10 0.0009
816 POOR QUALITY SLEEP 19 0.0009
817 PRODUCT PRESCRIBING ISSUE 19 0.0009
818 HAEMATOCHEZIA 48 0.0009
819 GASTRIC HAEMORRHAGE 10 0.0009
820 HAEMOPTYSIS 24 0.0009
821 URINARY TRACT INFECTION 145 0.0008
822 HAEMATOMA 22 0.0008
823 VENTRICULAR TACHYCARDIA 14 0.0008
824 FLUID RETENTION 43 0.0008
825 SKIN DISORDER 28 0.0008
826 PRESYNCOPE 20 0.0008
827 MOOD SWINGS 26 0.0008
828 AKATHISIA 11 0.0008
829 BACTERIAL INFECTION 15 0.0008
830 HYPOAESTHESIA ORAL 12 0.0008
831 DERMATITIS ALLERGIC 10 0.0008
832 FULL BLOOD COUNT DECREASED 16 0.0008
833 DIABETIC KETOACIDOSIS 19 0.0008
834 DERMATITIS CONTACT 9 0.0008
835 SEROTONIN SYNDROME 15 0.0008
836 ACUTE MYOCARDIAL INFARCTION 23 0.0008
837 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
838 LIMB DISCOMFORT 24 0.0008
839 CELLULITIS 39 0.0008
840 BRAIN FOG 12 0.0008
841 TINNITUS 35 0.0008
842 SKIN DISCOLOURATION 35 0.0008
843 HOSPITALISATION 117 0.0008
844 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 54 0.0008
845 PULMONARY CONGESTION 10 0.0008
846 ATAXIA 9 0.0008
847 FLATULENCE 43 0.0008
848 FEELING COLD 21 0.0008
849 ULCER 12 0.0008
850 GASTROINTESTINAL HAEMORRHAGE 63 0.0008
851 ABSCESS 12 0.0008
852 SINUS CONGESTION 10 0.0007
853 HEART RATE INCREASED 73 0.0007
854 SKIN LESION 20 0.0007
855 CEREBRAL HAEMORRHAGE 26 0.0007
856 PALPITATIONS 85 0.0007
857 DEPRESSED MOOD 38 0.0007
858 MASS 10 0.0007
859 VISION BLURRED 98 0.0007
860 BLOOD PRESSURE FLUCTUATION 17 0.0007
861 MENTAL IMPAIRMENT 17 0.0007
862 DRY SKIN 93 0.0007
863 RHABDOMYOLYSIS 29 0.0007
864 PULMONARY OEDEMA 31 0.0007
865 LUNG NEOPLASM MALIGNANT 28 0.0007
866 ABDOMINAL PAIN LOWER 17 0.0007
867 THROAT IRRITATION 30 0.0007
868 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
869 GASTROENTERITIS VIRAL 12 0.0007
870 TOOTHACHE 12 0.0007
871 ACUTE HEPATIC FAILURE 9 0.0007
872 DYSPHONIA 38 0.0006
873 LYMPHOMA 10 0.0006
874 SOMNOLENCE 130 0.0006
875 NEOPLASM MALIGNANT 43 0.0006
876 URINARY INCONTINENCE 19 0.0006
877 MYALGIA 109 0.0006
878 DEATH 546 0.0006
879 PRODUCT PREPARATION ERROR 13 0.0006
880 ORTHOSTATIC HYPOTENSION 11 0.0006
881 TREMOR 103 0.0006
882 SKIN EXFOLIATION 52 0.0006
883 BLOOD POTASSIUM INCREASED 10 0.0006
884 PELVIC PAIN 11 0.0006
885 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
886 PRURITUS GENERALISED 13 0.0006
887 OCULAR HYPERAEMIA 28 0.0006
888 PANCREATIC CARCINOMA 17 0.0006
889 RASH PAPULAR 13 0.0006
890 FEELING JITTERY 11 0.0006
891 DRUG INEFFECTIVE 758 0.0006
892 ARRHYTHMIA 27 0.0006
893 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102 0.0006
894 CYSTITIS 18 0.0006
895 HYPERSOMNIA 16 0.0006
896 DRUG ADMINISTRATION ERROR 17 0.0006
897 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
898 PSORIASIS 71 0.0005
899 SKIN ULCER 14 0.0005
900 CYTOMEGALOVIRUS INFECTION 9 0.0005
901 FEELING ABNORMAL 129 0.0005
902 CATARACT 32 0.0005
903 RENAL DISORDER 25 0.0005
904 PREMATURE BABY 16 0.0005
905 AGITATION 39 0.0005
906 POLLAKIURIA 22 0.0005
907 PRODUCT AVAILABILITY ISSUE 12 0.0005
908 LACTIC ACIDOSIS 17 0.0005
909 WRONG TECHNIQUE IN DRUG USAGE PROCESS 19 0.0005
910 PRODUCT QUALITY ISSUE 71 0.0005
911 EMOTIONAL DISTRESS 63 0.0005
912 PAIN OF SKIN 14 0.0005
913 ANGIOEDEMA 23 0.0005
914 FOETAL EXPOSURE DURING PREGNANCY 42 0.0005
915 CHOKING 10 0.0005
916 FUNGAL INFECTION 17 0.0005
917 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
918 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
919 DIPLOPIA 13 0.0005
920 BLOOD PRESSURE INCREASED 76 0.0005
921 SEDATION 13 0.0005
922 DYSKINESIA 20 0.0005
923 VISUAL ACUITY REDUCED 16 0.0005
924 LYMPHADENOPATHY 17 0.0005
925 RESPIRATORY ARREST 13 0.0005
926 BLINDNESS 19 0.0005
927 PRODUCT PRESCRIBING ERROR 11 0.0005
928 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
929 HERPES ZOSTER 26 0.0005
930 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
931 NERVOUS SYSTEM DISORDER 14 0.0004
932 OSTEONECROSIS OF JAW 11 0.0004
933 HYPOGLYCAEMIA 21 0.0004
934 BURNING SENSATION 30 0.0004
935 OSTEONECROSIS 14 0.0004
936 VIRAL INFECTION 14 0.0004
937 FAECES DISCOLOURED 9 0.0004
938 HALLUCINATION 31 0.0004
939 HAEMORRHAGE 43 0.0004
940 COVID-19 70 0.0004
941 CHOLELITHIASIS 13 0.0004
942 CEREBROVASCULAR ACCIDENT 67 0.0004
943 LIP SWELLING 13 0.0004
944 ACCIDENTAL OVERDOSE 14 0.0004
945 DRUG DOSE OMISSION 63 0.0004
946 DYSSTASIA 11 0.0004
947 SPEECH DISORDER 19 0.0004
948 DRY EYE 18 0.0004
949 CRYING 13 0.0004
950 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
951 FALL 118 0.0004
952 INJECTION SITE MASS 13 0.0004
953 FEAR 9 0.0003
954 HYPOACUSIS 14 0.0003
955 OVERDOSE 70 0.0003
956 GASTRIC DISORDER 11 0.0003
957 DIABETES MELLITUS 24 0.0003
958 INFLUENZA 35 0.0003
959 HEART RATE DECREASED 11 0.0003
960 INTENTIONAL PRODUCT MISUSE 27 0.0003
961 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
962 THERAPY CESSATION 15 0.0003
963 TOXICITY TO VARIOUS AGENTS 47 0.0003
964 ABNORMAL BEHAVIOUR 11 0.0003
965 EYE PAIN 15 0.0003
966 AGGRESSION 13 0.0003
967 COGNITIVE DISORDER 12 0.0003
968 SURGERY 15 0.0003
969 BLOOD GLUCOSE INCREASED 47 0.0002
970 NERVOUSNESS 13 0.0002
971 MYOCARDIAL INFARCTION 43 0.0002
972 ILLNESS 25 0.0002
973 SKIN BURNING SENSATION 17 0.0002
974 BALANCE DISORDER 19 0.0002
975 PRODUCT DOSE OMISSION 14 0.0002
976 COLORECTAL CANCER 10 0.0002
977 BREAST CANCER 19 0.0002
978 IRRITABILITY 12 0.0002
979 INFLUENZA LIKE ILLNESS 16 0.0002
980 THERAPY INTERRUPTED 13 0.0002
981 CARDIAC FAILURE CONGESTIVE 14 0.0002
982 EYE IRRITATION 10 0.0002
983 UNEVALUABLE EVENT 13 0.0002
984 CARDIAC DISORDER 16 0.0002
985 PRODUCT DOSE OMISSION ISSUE 50 0.0002
986 DISTURBANCE IN ATTENTION 9 0.0002
987 INJECTION SITE REACTION 11 0.0002
988 ACNE 10 0.0001
989 INJECTION SITE ERYTHEMA 15 0.0001
990 SUICIDAL IDEATION 11 0.0001
991 CHRONIC KIDNEY DISEASE 9 0.0001
992 INCORRECT DOSE ADMINISTERED 23 0.0001
993 DEVICE ISSUE 9 0.0001
994 INJECTION SITE PAIN 25 0.0001
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001